Jpmorgan Chase & CO Axogen, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Axogen, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 275,998 shares of AXGN stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275,998

Previous 310,568 11.13%

Holding current value

$3.91 Million

Previous $5.12 Million 0.25%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$14.56 - $20.11 $503,339 - $695,202	-34,570 Reduced 11.13%	275,998 $5.11 Million
Q4 2024 Feb 12, 2025	SELL	$12.47 - $17.19 $2.97 Million - $4.1 Million	-238,432 Reduced 43.43%	310,568 $5.12 Million
Q3 2024 Dec 26, 2024	BUY	$7.52 - $14.69 $3.99 Million - $7.8 Million	530,775 Added 2912.35%	549,000 $7.7 Million
Q3 2024 Nov 08, 2024	BUY	$7.52 - $14.69 $3.99 Million - $7.8 Million	530,775 Added 2912.35%	549,000 $7.7 Million
Q2 2024 Dec 26, 2024	SELL	$5.67 - $8.06 $3.01 Million - $4.28 Million	-530,775 Reduced 96.68%	18,225 $131,000
Q2 2024 Aug 12, 2024	BUY	$5.67 - $8.06 $10,240 - $14,556	1,806 Added 11.0%	18,225 $131,000
Q1 2024 Dec 26, 2024	SELL	$6.63 - $10.69 $3.53 Million - $5.69 Million	-532,581 Reduced 97.01%	16,419 $132,000
Q1 2024 May 10, 2024	SELL	$6.63 - $10.69 $69,469 - $112,009	-10,478 Reduced 38.96%	16,419 $132,000
Q4 2023 Dec 26, 2024	SELL	$3.61 - $7.76 $1.88 Million - $4.05 Million	-522,103 Reduced 95.1%	26,897 $183,000
Q4 2023 Feb 12, 2024	SELL	$3.61 - $7.76 $3,299 - $7,092	-914 Reduced 3.29%	26,897 $183,000
Q3 2023 Nov 14, 2023	SELL	$4.68 - $9.26 $21,565 - $42,670	-4,608 Reduced 14.21%	27,811 $139,000
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $3,978 - $4,857	468 Added 1.46%	32,419 $295,000
Q1 2023 May 18, 2023	BUY	$7.53 - $10.95 $233,889 - $340,117	31,061 Added 3490.0%	31,951 $301,000
Q1 2023 May 11, 2023	SELL	$7.53 - $10.95 $173,355 - $252,090	-23,022 Reduced 96.28%	890 $8,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $15,217 - $21,101	1,612 Added 7.23%	23,912 $238,000
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $3,646 - $5,488	448 Added 2.05%	22,300 $266,000
Q2 2022 Aug 11, 2022	BUY	$6.99 - $10.0 $23,577 - $33,730	3,373 Added 18.25%	21,852 $179,000
Q1 2022 May 11, 2022	BUY	$7.26 - $10.7 $24,662 - $36,347	3,397 Added 22.52%	18,479 $146,000
Q4 2021 Feb 10, 2022	SELL	$8.8 - $16.0 $77,704 - $141,280	-8,830 Reduced 36.93%	15,082 $142,000
Q3 2021 Nov 12, 2021	BUY	$15.23 - $21.72 $364,179 - $519,368	23,912 New	23,912 $378,000

Others Institutions Holding AXGN

# of Institutions

171

Shares Held

40.3M

Call Options Held

69.1K

Put Options Held

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $599M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Axogen, Inc. Transaction History